salen has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, T; Aoki, I; Eguchi, H; Fujita, T; Hara, M; Hoshino, Y; Ishiba, M; Ishikawa, Y; Kawahara, N; Kim, JH; Masuda, T; Muramoto, T; Murata, H; Nagasako, A; Nakayama, T; Oda, K; Ohtake, M; Sato, I; Takemura, Y; Tokura, S; Umemura, M; Yamada, S; Yokoyama, U | 1 |
1 other study(ies) available for salen and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ethylenediamines; Glioblastoma; Humans; Hyperthermia, Induced; Mice; Nanoparticles; Rats; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |